
Academic Journal
Q2Frontiers in Clinical Diabetes and Healthcare
About Frontiers in Clinical Diabetes and Healthcare
Frontiers in Clinical Diabetes and Healthcare is a scholarly journal published by Frontiers Media SA. SCImago 2025 lists it in Q2, with an SJR of 0.837 and H-index of 15.
Coverage: 2020-2026. Research categories: Endocrinology, Diabetes and Metabolism (Q2).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-03-12. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Diabetes Management and Research; Diabetes Management and Education; Diabetes, Cardiovascular Risks, and Lipoproteins; Diabetes Treatment and Management; Diabetes and associated disorders; Mobile Health and mHealth Applications.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
“This is going to be a nice-to-know, not a need-to-know”: absence of concern – a qualitative study of risk perception in early detection of type 1 diabetes
Emilia Bjergskov Pedersen, Pernille Bech Flarup, Louise Norman Jespersen, Mette Due-Christensen et al.
2026-10-02 · DOI: 10.3389/fcdhc.2026.1925120Prediction of metabolic dysfunction-associated steatotic liver disease among patients with type 2 diabetes mellitus using liver fat indices in a resource-limited clinical setting
KKDSD Kannangara, WAC Karunarathne, NRP Perera, Uditha Bulugahapitiya et al.
2026-09-25 · DOI: 10.3389/fcdhc.2026.1916533Toward standardized continuous glucose monitoring validation: lessons from the Sinocare iCan i3 accuracy study
Auda Ameur
2026-09-16 · DOI: 10.3389/fcdhc.2026.1941126The correlation between serum magnesium, phosphorus, and calcium levels during pregnancy and the risk of gestational diabetes mellitus as well as adverse pregnancy outcomes
Achou Su, Jie Zhang, Xizhenzi Fan, Wenhui Song et al.
2026-09-15 · DOI: 10.3389/fcdhc.2026.1939424Fetal behavior as a window to later gross motor function: a 10-year follow-up of children prenatally exposed to gestational diabetes mellitus
Oliver Vasilj, Dora Marinić, Tatjana Trošt, Zoran Žeželj et al.
2026-09-11 · DOI: 10.3389/fcdhc.2026.1938676COVID-19 pandemic and the management of type-2 diabetes mellitus among women in Fiji: concerns and context specific interventions
Eunice Okyere, Kissinger Marfoh, Ramneek Goundar, Litia Makutu et al.
2026-09-11 · DOI: 10.3389/fcdhc.2026.1846673Editorial: Oxidative stress and inflammation in type 2 diabetes: pathways to organ complications
Toshiki Otoda, Teruki Miyake, Shusuke Yagi, Ken-ichi Aihara et al.
2026-09-09 · DOI: 10.3389/fcdhc.2026.1976753Moisturizer formulations for diabetic foot xerosis: a systematic review and meta-analysis of randomized controlled trials
Karin Borgström, Sebastian Björklund, Petri Gudmundsson, Anna Ericsson et al.
2026-09-03 · DOI: 10.3389/fcdhc.2026.1922860Single-cell RNA sequencing in diabetic foot ulcers: pathogenesis, biomarkers, and translational potential
Shuhan Yang, Siqian Wang, Ruiyi Yang, Ke Xu et al.
2026-09-03 · DOI: 10.3389/fcdhc.2026.1833678Social determinants of health influencing diabetes self-care behaviors among immigrants: a scoping review
Rie Kudoh, Taiga Shibayama
2026-09-01 · DOI: 10.3389/fcdhc.2026.1915588Decoding RAGE in diabetes: a pathogenic signaling hub modulated by decoy receptors in diabetic complications
Yupa Srithongchai, Ai Harashima, Seiichi Munesue, Kumi Kimura et al.
2026-08-26 · DOI: 10.3389/fcdhc.2026.1854214Assessment of the impact of body mass index on right ventricular systolic and diastolic function in patients with type 2 diabetes mellitus using two-dimensional speckle tracking imaging
Wenwen Wang, Yuanyuan Peng, Kun Zhao, Ziwei Zheng et al.
2026-08-26 · DOI: 10.3389/fcdhc.2026.1694955Real-world outcomes of sitagliptin and sitagliptin/metformin single-pill combination treatment in diverse type 2 diabetes populations (DIVERSITY study)
Andrej Janez, Mirjana Bojic, Tomislav Bozek, Zdravko Kamenov et al.
2026-08-26 · DOI: 10.3389/fcdhc.2026.1905393Outcomes of the Sustainable Culturally Adapted Nutrition Program (SCAN) and food supplement program to improve engagement with the National Diabetes Prevention Program (NDPP)
William B. Perkison, Pierre Fwelo, Natalia I. Heredia, Ella Garza et al.
2026-08-24 · DOI: 10.3389/fcdhc.2026.1838175Bone morphogenetic protein 4-associated mitochondrial dysfunction in diabetic nephropathy involves Parkin downregulation
Masanori Tamaki, Tatsuya Tominaga, Kazuhiro Hasegawa, Takahiro Kida et al.
2026-08-11 · DOI: 10.3389/fcdhc.2026.1860424Economic evaluation of liraglutide versus sitagliptin in the treatment of type 2 diabetes mellitus inadequately controlled with metformin
Fengkun Yang, Xiaohui Zheng, Wenqi Li, Zhenying Zhao et al.
2026-08-07 · DOI: 10.3389/fcdhc.2026.1906364Metabolic and clinical markers of T2D in obese Indians: an age-sex matched case-control study
Anagha Vyawahare, Pramod Tripathi, Nidhi Kadam, Diptika Tiwari et al.
2026-08-05 · DOI: 10.3389/fcdhc.2026.1809646Construction of a dynamic prediction model for diabetic retinopathy risk in adults with adult-onset type 1 diabetes: a real-world longitudinal cohort study
Di Bao, Yingying Li, Chun Mu, Qiuling Xing et al.
2026-07-28 · DOI: 10.3389/fcdhc.2026.1873754Dapagliflozin & pioglitazone combination therapy in T2DM with or without MASLD - a systematic review and meta-analysis: PRO-2 study
Shashank Joshi, Shambo Samrat Samajdar, Arvind Gupta, Mithun Bhartia et al.
2026-07-20 · DOI: 10.3389/fcdhc.2026.1733995Is maternal diabetes associated with autism spectrum disorder and ADHD in the offspring? A short review
Salam Alshammaa, Bashair M. Mussa, Amena Sadiya, Salah Abusnana et al.
2026-07-15 · DOI: 10.3389/fcdhc.2026.1855251Reviews
Community Reviews
Version History
October 2, 2026 at 8:40 pm
October 2, 2026